The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house U.S. site to make the blockbuster ...

An anchor announcement at today's TELUS Health Annual Conference, TELUS Health revealed the results of its 2025 Drug Data Trends and National Benchmarks Report, offering an industry-wide snapshot of ...

PEP Health, the AI-powered patient experience platform trusted by leading hospitals, payers, and health systems, today announced the launch of its Trust Score, the first real-time, validated metric ...

SpringWorks sells two rare tumors drugs in the US and has two precision oncology drugs in early-stage development.